1993 JAN 01 COVID 19 & Obesity Comorbidity linked with Zinc Deficiency, Companion Medication (HCQ + Zinc)

Why is ZINC with HCQ important in treatment for COVID-19 and has Comorbidity of Obesity , Zinc Deficiency is linked to the Comorbidity of Obesity and the hydroxychloroquine, “opens the zinc channel” allowing the zinc to enter the cell, which then “blocks the replication of cellular machinery.” In this instance, chloroquine has no drug action. It is the zinc that is in play. Continue Reading

2011 DEC 07 COVID 19 & Asthma Comorbidity linked with Zinc Deficiency, Companion Medication (HCQ + Zinc)

Why is ZINC with HCQ important in treatment for COVID-19 and has Comorbidity of Asthma , Zinc Deficiency is linked to the Comorbidity of Asthma and the hydroxychloroquine, “opens the zinc channel” allowing the zinc to enter the cell, which then “blocks the replication of cellular machinery.” In this instance, chloroquine has no drug action. It is the zinc that is in play. Continue Reading

2018 JAN 11 COVID 19 & Chronic Obstructive Pulmonary Disease Comorbidity linked with Zinc Deficiency, Companion Medication (HCQ + Zinc)

Why is ZINC with HCQ important in treatment for COVID-19 and has Comorbidity of Chronic Obstructive Pulmonary Disease (COPD), Zinc Deficiency is linked to the Comorbidity of Chronic Obstructive Pulmonary Disease (COPD) and the hydroxychloroquine, “opens the zinc channel” allowing the zinc to enter the cell, which then “blocks the replication of cellular machinery.” In this instance, chloroquine has no drug action. It is the zinc that is in play. Continue Reading

2019 JAN 24 COVID 19 & Hypertension Comorbidity linked with Zinc Deficiency, Companion Medication (HCQ + Zinc)

Why is ZINC with HCQ important in treatment for COVID-19 and has Comorbidity of Hypertension , Zinc Deficiency is linked to the Comorbidity of Hypertension and the hydroxychloroquine, “opens the zinc channel” allowing the zinc to enter the cell, which then “blocks the replication of cellular machinery.” In this instance, chloroquine has no drug action. It is the zinc that is in play. Continue Reading

2005 FEB 01 COVID 19 & Taste and Smell Loss Comorbidity linked with Zinc Deficiency, Companion Medication (HCQ + Zinc)

Why is ZINC with HCQ important in treatment for COVID-19 and has Comorbidity of Taste and Smell Loss , Zinc Deficiency is linked to the Comorbidity of Taste and Smell Loss and the hydroxychloroquine, “opens the zinc channel” allowing the zinc to enter the cell, which then “blocks the replication of cellular machinery.” In this instance, chloroquine has no drug action. It is the zinc that is in play. Continue Reading

1999 OCT 01 COVID 19 & Diarrhea Comorbidity linked with Zinc Deficiency, Companion Medication (HCQ + Zinc)

Why is ZINC with HCQ important in treatment for COVID-19 and has Comorbidity of Diarrhea , Zinc Deficiency is linked to the Comorbidity of Diarrhea and the hydroxychloroquine, “opens the zinc channel” allowing the zinc to enter the cell, which then “blocks the replication of cellular machinery.” In this instance, chloroquine has no drug action. It is the zinc that is in play. Continue Reading

2020 SEP STUDY REVIEW; Says Hydroxychloroquine is Effective and Safe for the Treatment of COVID-19 (researchgate)

Hydroxychloroquine is Effective and Safe for the Treatment of COVID-19, and May be Universally Effective When Used Early Before Hospitalization and the CONCLUSION WAS HCQ is consistently effective against COVID-19 when used early in the outpatient setting, it is overall effective against COVID-19, it has not produced worsening, it is safe. Continue Reading